Fred Lorenzen

Fred Lorenzen is a finance professional with extensive experience in financial management and analysis, currently serving as Senior Manager, Finance at Reaction Biology since May 2023. Prior positions include Senior Manager and Finance Lead at TransCelerate BioPharma Inc. from June 2017 to May 2023, as well as Finance Manager and Senior Financial Analyst at Penn Medicine, University of Pennsylvania Health System from December 2013 to June 2017. Earlier in the career, Fred held roles as a Financial Analyst at Thomas Jefferson University and as an Accountant at Icahn School of Medicine at Mount Sinai. Fred Lorenzen earned an MBA in Strategic Management and Analytics from Villanova University and a BS in Finance from Saint Joseph's University - Erivan K. Haub School of Business.